Owners, management and financials
CVR: 36960566
Secondary names: 2care4. ApS, AFORTAS ApS
DKK 52,415,000
Gross profit
Net result: DKK 11,207,000
2care4 Group ApS (100%)
CVR · view owners
Thomas Hørslev Hedegaard, Ulrik Kronborg Markussen
Board: Erik Sandberg (chair) and 1 member
CVR · view management
Active
Founded 10 July 2015
CVR · view overview
32 employees
CVR · 2026
Director registered: Ulrik Kronborg Markussen
CVR · 01/10/2026
View the full event history
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Thomas Hørslev Hedegaard and Ulrik Kronborg Markussen. The board consists of Erik Sandberg (chair) and Toke Værndal. The company is owned by 2care4 Group ApS. The company has 32 employees (2026). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.
Source: annual report 2025, Danish Business Authority
The financial health of 2care4 Generics ApS appears robust, with a consistent trend of profitability over the past few years. Gross profit has shown a steady increase from 55.9 million DKK in 2021 to 73.4 million DKK in 2023, while net profit also rose significantly from 29.1 million DKK in 2021 to 31.6 million DKK in 2023, indicating strong operational efficiency and effective cost management. Equity has grown from 44.6 million DKK in 2021 to 86.5 million DKK in 2023, reflecting a solid financial foundation. However, the lack of disclosed revenue figures raises concerns about transparency and overall sales performance. Positioned within the wholesale trade of pharmaceuticals and medical supplies, the company benefits from a growing market, but its future trajectory will depend on maintaining profitability and addressing revenue visibility.
AI-generated summary · Generated 12/08/2026
Selskabets formål er at udvikle, importere, producere, forhandle og eksportere lægemidler samt anden dermed i naturlig forbindelse stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 52.4 mio. | 11.2 mio. | 115.2 mio. | 49.9 mio. | 29 | |
| 202401/01/2024 – 31/12/2024 | 58.2 mio. | 17.2 mio. | 129.7 mio. | 78.7 mio. | 20 | |
| 202301/01/2023 – 31/12/2023 | 73.4 mio. | 31.6 mio. | 170.4 mio. | 86.5 mio. | 15 | |
| 202201/01/2022 – 31/12/2022 | 75.7 mio. | 34.6 mio. | 171 mio. | 74.2 mio. | 12 | |
| 202101/01/2021 – 31/12/2021 | 55.9 mio. | 29.1 mio. | 127.8 mio. | 44.6 mio. | 15 | |
| 202001/01/2020 – 31/12/2020 | 32.9 mio. | 15.7 mio. | 72.4 mio. | 15.5 mio. | 12 | |
| 201901/01/2019 – 31/12/2019 | 8 mio. | -599 t. | 35.4 mio. | -166 t. | 8 | |
| 201801/01/2018 – 31/12/2018 | 3.3 mio. | -2.9 mio. | 21.3 mio. | 434 t. | 7 | |
| 201701/01/2017 – 31/12/2017 | -1.5 mio. | -6 mio. | 12.4 mio. | 330 t. | 5 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
10 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of 2care4 Generics ApS is 36960566.
2care4 Generics ApS is owned by 2care4 Group ApS.
The management of 2care4 Generics ApS consists of Thomas Hørslev Hedegaard and Ulrik Kronborg Markussen.
The board of 2care4 Generics ApS consists of Erik Sandberg and Toke Værndal, with Erik Sandberg as chair.
In 2025, 2care4 Generics ApS reported a gross profit of DKK 52,415,000.
2care4 Generics ApS had 32 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
2care4 Generics ApS has won the tender "Amgros 2027 2.1303.b" issued by Amgros I/S worth 5,735,454 DKK.
2care4 Generics ApS has won the tender "Amgros 2027 2.3.b" issued by Amgros I/S worth 690,861,598 DKK.
Contact info changed: new phone: 76101500, new email: [email protected], new website: www.2care4generics.dk (October 2, 2026).
As of October 1, 2026, Erik Sandberg has joined the board of directors of 2care4 Generics ApS.
As of October 1, 2026, Ulrik Kronborg Markussen is registered as director of 2care4 Generics ApS.
As of October 1, 2026, Thomas Hørslev Hedegaard is registered as adm. dir. of 2care4 Generics ApS.
As of October 1, 2026, Erik Sandberg has stepped down as adm. dir. of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2025. Gross profit came to DKK 52,415,000, and the net result was DKK 11,207,000.
Contact info changed: new phone: 76101500, new email: [email protected], new website: www.2care4generics.dk (March 26, 2026).
As of March 24, 2026, Erik Sandberg is registered as adm. dir. of 2care4 Generics ApS.
As of March 24, 2026, Ulrik Ernst Rasmussen has stepped down as adm. dir. of 2care4 Generics ApS.
As of December 16, 2025, Henrik Bisgaard Jensen has left the board of directors of 2care4 Generics ApS.
As of December 1, 2025, Thomas Hjarsbæk Rasmussen has stepped down as director of 2care4 Generics ApS.
2care4 Generics ApS has won the tender "Amgros 2026 1.1212.a" issued by Amgros I/S worth 44,707,811 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 2.1303.b" issued by Amgros I/S worth 4,100,779 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 1.603.a" issued by Amgros I/S worth 7,867,813 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 2.290.b" issued by Amgros I/S worth 88,050,546 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 2.703.b" issued by Amgros I/S worth 66,045,550 DKK.
2care4 Generics ApS has won the tender "Amgros 2026 1.700.a" issued by Amgros I/S worth 245,033,539 DKK.
2care4 Generics ApS has published its annual report for 2024. Gross profit came to DKK 58,190,000, and the net result was DKK 17,193,000.
2care4 Generics ApS has won the tender "Amgros 2025 1.1312.b" issued by Amgros I/S worth 1,997,154 DKK.
2care4 Generics ApS has won the tender "Amgros 2025 1.290.b" issued by Amgros I/S worth 4,463,413 DKK.
2care4 Generics ApS has published its annual report for 2023. Gross profit came to DKK 73,414,000, and the net result was DKK 31,564,000.
As of April 25, 2024, Thomas Hjarsbæk Rasmussen is registered as director of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2022. Gross profit came to DKK 75,691,000, and the net result was DKK 34,598,000.
2care4 Generics ApS has published its annual report for 2021. Gross profit came to DKK 55,862,884, and the net result was DKK 29,082,540.
2care4 Generics ApS has published its annual report for 2020. Gross profit came to DKK 32,852,182, and the net result was DKK 15,714,624.
2care4 Generics ApS has published its annual report for 2019. Gross profit came to DKK 7,988,765, and the net result was DKK -599,230.
As of September 6, 2019, Torben Børsting has stepped down as director of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2018. Gross profit came to DKK 3,260,793, and the net result was DKK -2,896,734.
As of May 1, 2019, Torben Børsting has left the board of directors of 2care4 Generics ApS.
As of May 1, 2019, Ulrik Ernst Rasmussen is registered as adm. dir. of 2care4 Generics ApS.
As of May 1, 2019, Toke Værndal has stepped down as adm. dir. of 2care4 Generics ApS.
As of August 31, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2care4 Generics ApS.
As of August 31, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2017. Gross profit came to DKK -1,519,397, and the net result was DKK -6,026,345.
As of February 12, 2018, Torben Børsting has joined the board of directors of 2care4 Generics ApS.
As of February 12, 2018, Henrik Fomsgaard-Knudsen has left the board of directors of 2care4 Generics ApS.
As of February 12, 2018, Toke Værndal is registered as adm. dir. of 2care4 Generics ApS.
As of February 12, 2018, Torben Børsting is registered as director of 2care4 Generics ApS.
As of February 12, 2018, Henrik Fomsgaard-Knudsen has stepped down as adm. dir. of 2care4 Generics ApS.
2care4 Generics ApS has published its interim report for the period July 10, 2015 to December 31, 2016.
As of August 29, 2016, Henrik Fomsgaard-Knudsen has joined the board of directors of 2care4 Generics ApS.
As of August 29, 2016, Toke Værndal has joined the board of directors of 2care4 Generics ApS.
As of August 29, 2016, Henrik Bisgaard Jensen has joined the board of directors of 2care4 Generics ApS.
As of April 19, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2care4 Generics ApS.
As of April 19, 2016, EY Godkendt Revisionspartnerselskab has stepped down as auditor of 2care4 Generics ApS.
As of July 10, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of 2care4 Generics ApS.
As of July 10, 2015, Henrik Fomsgaard-Knudsen is registered as adm. dir. of 2care4 Generics ApS.
As of July 10, 2015, 2care4 Group ApS is registered as an owner of 2care4 Generics ApS with an ownership share of 100%.
2care4 Generics ApS was founded on July 10, 2015.
Companies in the same industry and area
CVR 25615697
CVR 28964080
CVR 16249092
CVR 31605822
CVR 36893419
